title: Pregabalin treatment of anxiety in patients with substance use disorders.
authors.forename: Shafi
authors.initials: S
authors.lastname: Raza
authors.forename: Umar A
authors.initials: UA
authors.lastname: Siddiqui
authors.forename: James L
authors.initials: JL
authors.lastname: Megna
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Schwartz
authors.forename: Steven L
authors.initials: SL
authors.lastname: Batki
mesh_terms: D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001007:Anxiety / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069583:Pregabalin; D019966:Substance-Related Disorders / Q000150:complications* / Q000523:psychology; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D014151:Anti-Anxiety Agents; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid